A phase 1, randomized, controlled clinical trial of CC-11050, a novel PDE4 inhibitor, in human immunodeficiency virus-1-infected adults with suppressed plasma viremia on antiretroviral therapy (APHRODITE).
A phase 1, randomized, controlled clinical trial of CC-11050, a novel PDE4 inhibitor, in human immunodeficiency virus-1-infected adults with suppressed plasma viremia on antiretroviral therapy (APHRODITE).
- 2019
MedStar Georgetown University Hospital Residents
Poster presented at
MedStar Georgetown University Hospital Residents
Poster presented at